Oncoinvent ASA (OSL:ONCIN)

Oncoinvent ASA Revenue

In the year 2025, Oncoinvent ASA had annual revenue of 28.07M NOK with 246.40% growth. Oncoinvent ASA had revenue of 16.11M in the half year ending December 31, 2025, with 192.20% growth.

• Revenue: 28.07M
• Revenue Growth: +246.40%
• P/S Ratio: 6.86
• Revenue / Employee: 637.93K
• Employees: 44
• Market Cap: 192.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	28.07M	19.97M	246.40%
Dec 31, 2024	8.10M	2.31M	39.95%
Dec 31, 2023	5.79M	-493.00K	-7.85%
Dec 31, 2022	6.28M	-4.80M	-43.31%
Dec 31, 2021	11.08M	705.85K	6.80%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 3, 2026

Data Sources Report a data error